miR-351 通过抑制 ITGB3/PIK3R1/Akt 通路促进糖尿病中的动脉粥样硬化,并诱导内皮细胞损伤和脂质积累。
miR-351 promotes atherosclerosis in diabetes by inhibiting the ITGB3/PIK3R1/Akt pathway and induces endothelial cell injury and lipid accumulation.
机构信息
Department of Cardiovascular, Shengjing Hospital of China Medical University, Shenyang, China.
School of Pharmacy, China Medical University, Shenyang, China.
出版信息
Mol Med. 2022 Sep 30;28(1):120. doi: 10.1186/s10020-022-00547-9.
BACKGROUND
The miR-351 gene is significantly upregulated in diabetic mice with atherosclerosis. However, the mechanism by which its presence is important for the overall disease has not been elucidated. Therefore, this study will investigate the mechanism of miR-351 in the process of diabetes mellitus with atherosclerosis through miR-351 gene knockout mice.
METHODS
In this study, miR-351 C57BL/6 mice were first induced to form a type 2 diabetes mellitus model with atherosclerosis by STZ injection and a high-fat diet. Pathological tests (oil red O, HE, and Masson staining) combined with biochemical indices (TC, TG, LDL-C, HDL-C, TNF-α, hs-CRP, NO, SOD, MDA, CAT, and GSH-Px) were performed to evaluate the pathological degree of atherosclerosis in each group. Mouse aortic endothelial cells were treated with oxidized low-density lipoprotein (ox-LDL) and 30 mM glucose to establish a diabetic atherosclerosis cell model. Combined with cell oil red O staining and flow cytometry, the effects of silencing miR-351 on lipid accumulation and cell apoptosis in the diabetic atherosclerosis cell model were determined. Fluorescence in situ hybridization was used to detect the localization and transcription levels of miR-351 in cells. The target genes of miR-351 were predicted by bioinformatics and verified by dual-luciferase activity reporting. Western blotting was used to detect the expression levels of phosphorylated inosine 3-kinase regulatory subunit 1 (PIK3R1)/serine/threonine kinase 1 (Akt) and apoptosis-related proteins after transfection with integrin subunit β3 (ITGB3) small interfering ribonucleic acid (siRNA).
RESULTS
The expression of the miR-351 gene was significantly increased in the high-fat wild-type (HWT) group, and its expression was significantly decreased in the knockout mice. Silencing miR-351 effectively alleviated atherosclerosis in mice. The levels of miR-351 expression, apoptosis, lipid accumulation, and oxidative stress in ox-LDL + high glucose-induced endothelial cells were significantly increased. These phenomena were effectively inhibited in lentivirus-infected miR-351-silenced cell lines. Bioinformatics predicted that miR-351-5p could directly target the ITGB3 gene. Transfection of ITGB3 siRNA reversed the downregulation of apoptosis, decreased oil accumulation, and decreased oxidative stress levels induced by miR-351 silencing. In addition, it inhibited the activation of the PIK3R1/Akt pathway.
CONCLUSION
Silencing miR-351 upregulates ITGB3 and activates the PIK3R1/Akt pathway, thereby exerting anti-apoptosis and protective effects on endothelial cells.
背景
miR-351 基因在伴有动脉粥样硬化的糖尿病小鼠中显著上调。然而,其存在对整体疾病的重要性的机制尚未阐明。因此,本研究将通过 miR-351 基因敲除小鼠来研究 miR-351 在糖尿病伴动脉粥样硬化过程中的机制。
方法
本研究首先通过 STZ 注射和高脂饮食诱导 miR-351 C57BL/6 小鼠形成 2 型糖尿病伴动脉粥样硬化模型。通过病理检查(油红 O、HE 和 Masson 染色)和生化指标(TC、TG、LDL-C、HDL-C、TNF-α、hs-CRP、NO、SOD、MDA、CAT 和 GSH-Px)评估各组动脉粥样硬化的病理程度。用氧化型低密度脂蛋白(ox-LDL)和 30mM 葡萄糖处理小鼠主动脉内皮细胞,建立糖尿病动脉粥样硬化细胞模型。结合细胞油红 O 染色和流式细胞术,确定沉默 miR-351 对糖尿病动脉粥样硬化细胞模型中脂质积累和细胞凋亡的影响。荧光原位杂交检测 miR-351 在细胞中的定位和转录水平。通过生物信息学预测 miR-351 的靶基因,并通过双荧光素酶活性报告进行验证。转染整合素亚基 β3(ITGB3)小干扰 RNA(siRNA)后,用 Western blot 检测磷酸肌醇 3-激酶调节亚基 1(PIK3R1)/丝氨酸/苏氨酸激酶 1(Akt)和凋亡相关蛋白的表达水平。
结果
高脂野生型(HWT)组 miR-351 基因表达显著增加,敲除组表达显著降低。沉默 miR-351 可有效减轻小鼠动脉粥样硬化。ox-LDL+高葡萄糖诱导的内皮细胞中 miR-351 表达、细胞凋亡、脂质堆积和氧化应激水平明显升高。在感染了 miR-351 沉默慢病毒的细胞系中,这些现象得到了有效抑制。生物信息学预测 miR-351-5p 可直接靶向 ITGB3 基因。转染 ITGB3 siRNA 可逆转 miR-351 沉默诱导的细胞凋亡减少、脂质堆积减少和氧化应激水平降低,并抑制 PIK3R1/Akt 通路的激活。
结论
沉默 miR-351 可上调 ITGB3 并激活 PIK3R1/Akt 通路,从而对内皮细胞发挥抗凋亡和保护作用。